A B S T R A C T A direct neural role in the regulation of immunoreactive glucagon (IRG) secretion has been investigated during stimulation of mixed autonomic nerves to the pancreas in anesthetized dogs. The responses were evaluated by measurement of blood flow and hormone concentration in the venous effluent from the stimulated region of pancreas.
IRG molar output ratio, the function relating the two parameters being markedly nonlinear. Injection or primed infusion of glucose diminished the IRG response to simultaneous nerve stimulation.
Measurement of IRG was inferred to reflect response of pancreatic glucagon secretion on the basis of the site of sample collection (the superior pancreaticoduodenal vein), the absence of changes in arterial IRG, and similar responses being obtained using an antibody specific for pancreatic glucagon.
These studies support a role for the autonomic nervous system in the control of glucagon secretion: direct nerve stimulation induces glucagon release. Such sympathetic activation may be interpreted as capable of shifting the sensitivity of the A cell to glucose in the direction of higher glycemia for a given glucagon output. The experimental model employed is valid for further studies of regulatory mechanisms of endocrine pancreatic function in vivo.
INTRODUCTION
It is now widely accepted that a multiplicity of factors may either act independently to cause insulin release, or act in concert to regulate both the basal rate of insulin release and its response to stimulation by glucose. One important factor so identified is the autonomic nervous system. The demonstration of effects of autonomic neurotransmitters upon insulin secretion in vivo and in vitro (1) has only recently been followed by similar evidence for effects upon glucagon release in vitro (2, 3) . Yet, the latter might have been predicted from the growing evidence that pancreatic A and B cells form a "couple" in terms of their responsiveness to most physiologic stimuli (4, 5) ; also, from the electron microscopic evidence that both A and B cells of the islets of several spe-
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The Journal of Clinical Investigation Volume 52 May 1973 1246-1259 cies receive an ample supply of autonomic nerve fibers (6) (7) (8) (9) (10) (11) (12) ; finally, from the nature of the metabolic effects of glucagon, particularly upon the liver, since potent stimulation of glycogenolysis and gluconeogenesis would seem appropriate in states of stress or physical exertion, states in which increased sympathetic activity is known to occur.
The pharmacologic approach thus far employed cannot, however, establish that nervous activity itself may influence glucagon secretion, since the relevance of concentrations of neurotransmitters obtained by exogenous administration to the concentrations present at stimulated nerve terminals is not yet established. The same applies to concentrations of blocking agents. Accordingly, the present study of the effect of direct neural stimulation was undertaken. Mixed autonomic nerves (sympathetic and parasympathetic) to the pancreas were stimulated in anesthetized dogs in which flow and secretory responses were estimated in the superior pancreaticoduodenal vein.
METHODS
Animials and surgical procedures. 20 male and female mongrel dogs weighing 15-30 kg were prepared by fasting 18-24 h. Anesthesia was induced with thiopentone and maintained by continuous infusion of thiopentone and succinylcholine at doses determined by physiologic parameters. Ventilation was controlled by a positive pressure respirator after endotracheal intubation. Body temperature was controlled at 37.5-39.5°C by means of a heating blanket, as assessed both by a rectal mercury thermometer and by a needle thermoprobe inserted into the quadriceps muscle, since body temperature exerts a potent influence on endocrine pancreatic secretion (13) , and since it was observed that under the experimental conditions the body temperature showed a tendency to decrease. Femoral artery cannulation and use of a strain gauge (Beckman Instruments, Inc., Fullerton, Calif.) allowed for continuous recording of blood pressure and heart rate using a Beckman Dvnograph recorder type RM. Frequent sampling of arterial blood for estimation of pH, Pco2, and Po2 provided evidence for maintenance of acid-base equilibrium, and thus when indicated, ventilation was adjusted or additional Na bicarbonate was infused. These measures assured maintenance of arterial pH between 7.35-7.45 throughout all the experiments reported.
The surgical preparation was as described by Kanazawa, Kuzuya, and Ide (14) . In summary: after laparotomy the pancreas was visualized and its arterial and venous supplies identified. First, blood effluent from the pancreas via the superior pancreaticoduodenal vein was anticoagulated by cannulation of the inferiors pancreaticoduodenal vein with a polyethylene catheter through which heparin in saline (40 U/min in 0.1-0.2 ml) was infused at a rate which did not affect the outflow from the superior pancreaticoduodenal vein. Second, an extracorporeal circuit retaining the normal direction of flow was established by insertion of a teflon and silastic cannula into the superior pancreaticoduodenal vein. Flow was directed through the catheter, which was exteriorized through the abdominal incision, thence back into the portal vein. The distal limb was fixed with a pursestring suture. Length of the exteriorized portion was about 20 Plasma glucose was determined by a glucose-oxidase method. In five dogs a sample of liver was removed at the end of the experiment, immediately frozen in liquid nitrogen, and subsequently analyzed for glycogen content by glucose determination after acid hydrolysis. Hepatic glycogen content was 0.33±0.21 g/100 g liver (mean +SEM) in the five dogs.
Experimental protocols. Though individual protocols varied somewhat, either one or a combination of the following were performed in each instance: (a) glucose alone was injected as a pulse of 0.1 g/kg into the femoral vein; (b) nerve stimulation was performed as described, with or without prior administration of atropine, for either 10-or 20-min periods; (c) pulse glucose injection (0.1 g/kg)
was given 1 min after the commencement of nerve stimulation and the latter continued 11 min; (d) a primed infusion of glucose (0.1 g/kg pulse followed by 0.13 g/min) was given concurrent with 20 min nerve stimulation, i.e., both were started and terminated simultaneously. In all instances, a period of 30-0 min was allowed after each experimental intervention for equilibration of flow, and of the levels of glucose and hormones in plasma. In most instances, when two or more manipulations were performed, Fig. 2 are presented as integrated areas of release under the response curve for the 10 min period preceding (control) and after glucose. The one dog which failed to exhibit a decrease also had the lowest control value. By paired comparison, the fall in output was highly significant (P < 0.005). Fig. 3 . Glucose injection (producing hyperglycemia comparable to that in Fig. 1 ) decreased both the initial fall and subsequent increment in IRG output.
shown in Fig. 2 number of experiments reported above. By contrast, the glucose 98±9 mg/100 ml). Similarly, the prestimulation response was only 114±12% of control (P > 0.05) when (control) values for IRI output were 2.00±0.64 and glucose was infused. Total release for the control periods 2.07±0.78 mU/min, and for flow 27.2± 5.5 and 27.7±5.8 before the two stimulations was not different (P > 0.05). ml/min, respectively.
The glucose-induced diminution in response could not be When a longer period of stimulation was employed, accounted for by different prestimulation arterial plasma and hyperglycemia was prolonged by primed glucose inglucose concentrations (control value for stimulation fusion (Fig. 6) , a greater suppression of the response to alone was 95±7 mg/100 ml, and for stimulation plus nerve stimulation was apparent. Whereas 22) has not been completely excluded.
The hormonal response to glucose infusion confirms the validity of the model: the hyperglycemia that induced an IRI response also decreased IRG release, as is well documented in dogs in vivo (23, 24) and in vitro (20) , in man (25) , and in rats (26) However, data are not as yet available which define the endogenous activity of such nerves.
Analysis of the interaction between IRI and IRG. The data obtained have been analyzed with respect to the interaction of glucose, IRI, and IRG levels in two ways: first during the control state before perturbation and then, during the perturbations induced by glucose and nerve stimulation.
Steady-state conditions. Since the bivariate normality of the data was not assured, calculations included a regression analysis of both direct data and data after transformation. In all cases it was found that the best fit was obtained by linearized data, achieved by logarithmic transformation. The regression function is thus:
where X represents the arterial glucose concentration and Y the hormone output. The regression lines obtained with these data are shown in Fig. 9A . It was found that the output of IRI was positively correlated with the glucose concentration (logioY = -7.600 + 2.934 logioX, r = 0.654, P = 0.003). Though a negative correlation was suggested for IRG, it was not significant (r = -0.416, P = 0.063), and is probably related to a less sensitive control of IRG secretion in the range of glucose levels observed. However, the highest level of significance was observed for the correlation between IRI/IRG molar output ratio and glucose (logoY =-7.131 + 3.823 logioX, r = 0.704, P = 0.001).
This suggests that the circulating concentrations of the two hormones are not independent but coupled, at least via glucose concentration. Such an observation is, in general, consistent with previous hypotheses of the significance of IRI/IRG molar concentration ratio in peripheral blood (5). These findings further underscore that it is unrealistic to attempt to account for in vivo glucose regulation based on the kinetics of a single hormone system. It is also apparent from Fig. 9A that the bihormonal system of the present steady-state analysis is probably nonlinear.
Response to perturbations. The response of the glucagon system to glucose and to nerve stimulation was dependent not only on the nature of the stimulus, but also on the rate of hormone output just preceding. Thus, when the data of Figs. 2 and 4 are plotted, there is a relationship between the rate of change of glucagon output (Gon) and the corresponding control output (Gon), as shown in Fig. 9B . For the effect of glucose infusion, use of equation (1) as the regression function gave the line of best fit (logoY =-1.600 -1.599 logioX, where Y represents Gon and X, Gon, r = 0.763, P = 0.01). In addition to the simple effect of glucose infusion to decrease glucagon output, this correlation demonstrates that the lower the control IRG output, the smaller was the magnitude of the decrease.
By contrast, during nerve stimulation, the higher the control output, the greater was the magnitude of response. The best fit in this case was provided by a direct linear correlation (Y = -0.451 + 0.830X, r = 0.835, P = 0.003). Thus, whether or not these two perturbations interact at the same control point for glucagon release, the net effect of the nerve stimulation may be visualized as capable of shifting the set-point of A-cell responsiveness to a given glucose concentration. This is illustrated in Fig. 6 , in which the doubling of glucose concentration by primed infusion during nerve stimulation led to the same glucagon output despite hyperglycemia. A detailed analysis of these data in terms of control theory will be presented elsewhere. 3 The importance of blood flow to the pattern of hormione release. The onset of nerve stimulation produced a sharp drop in blood flow, with subsequent recovery toward control values during continuing stimulation (Fig. 3) . The question arises as to what extent changes in blood flow contributed to the variation in IRG output observed during that period. The IRG response could not have been a simple consequence of the initial fall in flow, since the total release over the period of stimulation was significantly greater than during the appropriate control period, and since the shape but not the magnitude of a response may be altered by flow over the time intervals studied. Only a change in contour would be expected since (as discussed under AMethods) the sampling point is at some distance from the point of secretion. The correlation presented in Fig. 9B allows for definition of the true shape of the response for the first minutes, since in first approximation, dGon/dt = A + B Gon.
The integration is straightforward, pine. This is consistent with the previously observed stimulation by adrenergic agents of IRG release from rat pancreas in vitro (2) , from perfused canine pancreas (3) , and in vivo in man (28) and ducks (29, 30 Unger (5) . In situations of "glucose need," decrease in insulin and increase in glucagon secretion are appropriate. Situations of heightened sympathetic activity are, in general, "stress" situations in which an increased supply of oxidative fuel in the form of endogenous glucose would be advantageous. Indeed, in exercise an increased secretion of glucagon has been demonstrated (26, (35) (36) (37) , and it is well known that the secretion of insulin is diminished. The cause of such altered secretion has not heretofore been demonstrated, but in exercise a role for hyperalaninemia is possible in man (38, 39) 'Wollheim, C. B., E. B. Marliss, B. Blondel, and L. Orci. though it does not occur in rats (40) . However, a more attractive hypothesis might be that the effects on both pancreatic hormones could be explained by a direct nervous mechanism. Plasma norephinephrine (but not epinephrine) levels rise in exercise (41) , implicating release of this neurotransmitter from nerve endings. The demonstration of elevated plasma levels is not a necessary concomitant of increased sympethetic activity, since high levels in proximity to A and B cells could undoubtedly occur in their absence. The latter is further supported by confirmation of the presence of appropriate nerve endings adjacent to the endocrine cells.
In other states of "glucose need," as well, it is possible that the neural induction of glucagon secretion could play a role. In extensive burns, the negative nitrogen balance, reflecting accelerated hepatic gluconeogenesis, might thus be mediated by hyperglucagonism. The observation that such protein wasting may be suppressed by infusion of large amounts of glucose and insulin (42) is also consistent with such a postulated mechanism. Such an effect might be analogous to the glucose reduction of glucagon release induced by nerve stimulation in the present study.
The acute rise in IRG in rats at birth may be related to neural activity, since fetal IRG release demonstrated by Girard, Bal, Assan, and Jost has been shown to be sluggish in response to hypoglycemia but brisk with norepinephrine infusion (43, 44) .
The most common disorder manifesting inappropriate or elevated plasma glucagon levels is diabetes mellitus (5, 25, 45, 46) . In light of the reported increase in catecholamine secretion in diabetic ketoacidosis (47, 48) , the markedly elevated glucagon levels seen may in part be contributed to by such adrenergic stimulation. Elevated plasma norephinephrine levels have recently been observed in nonketotic diabetics, in proportion to the metabolic derangement (48) . The possibility of disordered neural modulation in diabetes postulated by Burr, Taft, Stauffacher, and Renold (49) for insulin secretion could thus be extended to contribute to the inappropriately normal or elevated levels of glucagon, in this instance, not suppressed by hyperglycemia. Both of these effects could result from' a shift in the glucose "set point" of the A cell resulting from sympathetic stimulation as demonstrated in the present study.
